Eli Lilly has agreed to buy clinical-stage company Centessa Pharmaceuticals for an initial payment of about $6.3 billion in a ...

Centessa Pharmaceuticals PLC CNTA agreed to be acquired by Eli Lilly and Co LLY for a total value of around $8 billion, but ...

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

Centessa, which has headquarters in the U.K. and in Boston, has focused on disorders that leave people struggling to stay ...

Eli Lilly ​said ​on ​Tuesday it would buy Centessa ⁠Pharmaceuticals ‌in ⁠a deal valued at up to $7.8 billion as the U.S.

Eli Lilly LLY announced that it has entered into a definitive agreement to acquire U.K.-based Centessa Pharmaceuticals CNTA.

The company, which is flush with cash from sales of its market-leading GLP-1 franchise, has been an active dealmaker.

Eli Lilly & Co. agreed to buy sleep drug maker Centessa Pharmaceuticals Plc in a deal worth up to $7.8 billion, a sign the ...

Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult ...

Yahoo Finance Senior Reporter Brooke DiPalma takes a closer look at some of Tuesday morning's trending tickers and stories, ...

Eli Lilly is buying Centessa Pharmaceuticals in a deal worth at least $6.3 billion, picking up a promising narcolepsy ...

In the past 12 months, Lilly has bought cardiovascular-focused gene editing firm Verve Therapeutics for $1.3 billion, eye ...